These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15033403)

  • 1. Lost levonorgestrel IUD: diagnosis and therapy.
    Nitke S; Rabinerson D; Dekel A; Sheiner E; Kaplan B; Hackmon R
    Contraception; 2004 Apr; 69(4):289-93. PubMed ID: 15033403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
    Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
    Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levonorgestrel IUD].
    Skajaa K; Forman A
    Ugeskr Laeger; 1994 Nov; 156(46):6884-7. PubMed ID: 7839510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine devices and adolescents.
    Gold MA; Johnson LM
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):464-9. PubMed ID: 18797269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception.
    Sivin I
    Obstet Gynecol; 1991 Aug; 78(2):291-8. PubMed ID: 2067778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer.
    Dinger J; Bardenheuer K; Minh TD
    Contraception; 2011 Mar; 83(3):211-7. PubMed ID: 21310281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reasons for removal of intrauterine devices among women in general practice].
    Kolding L; Majeed HG
    Ugeskr Laeger; 2013 Mar; 175(13):884-6. PubMed ID: 23582897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care provider attitudes and practices related to intrauterine devices for nulliparous women.
    Tyler CP; Whiteman MK; Zapata LB; Curtis KM; Hillis SD; Marchbanks PA
    Obstet Gynecol; 2012 Apr; 119(4):762-71. PubMed ID: 22433340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2004 Aug; 70(2):169-72. PubMed ID: 15288224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation.
    Haimov-Kochman R; Doviner V; Amsalem H; Prus D; Adoni A; Lavy Y
    Hum Reprod; 2003 May; 18(5):990-3. PubMed ID: 12721174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine contraception: the role of general practitioners in four Dutch general practices.
    Vos AA; Veldhuis HM; Lagro-Janssen TL
    Contraception; 2004 Apr; 69(4):283-7. PubMed ID: 15033402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the type of intrauterine device affect conspicuity on 2D and 3D ultrasound?
    Moschos E; Twickler DM
    AJR Am J Roentgenol; 2011 Jun; 196(6):1439-43. PubMed ID: 21606311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation in vivo and in vitro of cervical mucus in IUD users: differences between women wearing copper and progesterone releasing IUDs.
    Scarselli G; Noci I; Chelo E; Tantini C; Livi C
    Acta Eur Fertil; 1983; 14(4):279-82. PubMed ID: 6689512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforated intraperitoneal intrauterine contraceptive devices: diagnosis, management, and clinical outcomes.
    Kho KA; Chamsy DJ
    J Minim Invasive Gynecol; 2014; 21(4):596-601. PubMed ID: 24462588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.